Innovus Pharmaceuticals Inc. (OTCQB: INNV) is an emerging leader in over-the-counter and consumer products for men's and women's health and vitality. These products are marketed in the U.S. and Canada through retailers and on the web.
The company's growing product portfolio includes Zestra for female arousal and desire, EjectDelay for premature ejaculation, Sensum to increase penile sensitivity, Vesele to promote sexual and cognitive health, and Zestra Glide for female lubrication. In total, the company has 13 commercial products that are on the market.
In addition, the company is actively seeking an ANDA from the FDA for FlutiCare, which is a nasal spray for the management of seasonal and perennial allergic and non-allergic rhinitis.